These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 25545744

  • 1. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
    Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ.
    Prostate; 2015 Apr 01; 75(5):550-9. PubMed ID: 25545744
    [Abstract] [Full Text] [Related]

  • 2. Re: Randomized Clinical Trial of Brewed Green and Black Tea in Men with Prostate Cancer Prior to Prostatectomy.
    Taneja SS.
    J Urol; 2015 Sep 01; 194(3):704-5. PubMed ID: 26292860
    [No Abstract] [Full Text] [Related]

  • 3. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
    Wang P, Aronson WJ, Huang M, Zhang Y, Lee RP, Heber D, Henning SM.
    Cancer Prev Res (Phila); 2010 Aug 01; 3(8):985-93. PubMed ID: 20628004
    [Abstract] [Full Text] [Related]

  • 4. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.
    Wang P, Henning SM, Magyar CE, Elshimali Y, Heber D, Vadgama JV.
    J Exp Clin Cancer Res; 2016 May 06; 35():73. PubMed ID: 27151407
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
    Freedland SJ, Carducci M, Kroeger N, Partin A, Rao JY, Jin Y, Kerkoutian S, Wu H, Li Y, Creel P, Mundy K, Gurganus R, Fedor H, King SA, Zhang Y, Heber D, Pantuck AJ.
    Cancer Prev Res (Phila); 2013 Oct 06; 6(10):1120-7. PubMed ID: 23985577
    [Abstract] [Full Text] [Related]

  • 6. Chemopreventive effects of tea in prostate cancer: green tea versus black tea.
    Henning SM, Wang P, Heber D.
    Mol Nutr Food Res; 2011 Jun 06; 55(6):905-20. PubMed ID: 21538852
    [Abstract] [Full Text] [Related]

  • 7. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
    Wang P, Vadgama JV, Said JW, Magyar CE, Doan N, Heber D, Henning SM.
    J Nutr Biochem; 2014 Jan 06; 25(1):73-80. PubMed ID: 24314868
    [Abstract] [Full Text] [Related]

  • 8. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
    Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH.
    Cancer Prev Res (Phila); 2012 Feb 06; 5(2):290-8. PubMed ID: 22044694
    [Abstract] [Full Text] [Related]

  • 9. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption.
    Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee RP, Lu J, Harris DM, Moro A, Hong J, Pak-Shan L, Barnard RJ, Ziaee HG, Csathy G, Go VL, Wang H, Heber D.
    J Nutr; 2006 Jul 06; 136(7):1839-43. PubMed ID: 16772446
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
    Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A.
    Clin Cancer Res; 2006 Jul 01; 12(13):4018-26. PubMed ID: 16818701
    [Abstract] [Full Text] [Related]

  • 11. A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.
    van Die MD, Williams SG, Emery J, Bone KM, Taylor JM, Lusk E, Pirotta MV.
    Prostate; 2017 May 01; 77(7):765-775. PubMed ID: 28181675
    [Abstract] [Full Text] [Related]

  • 12. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis.
    Henning SM, Wang P, Said J, Magyar C, Castor B, Doan N, Tosity C, Moro A, Gao K, Li L, Heber D.
    J Nutr Biochem; 2012 Nov 01; 23(11):1537-42. PubMed ID: 22405694
    [Abstract] [Full Text] [Related]

  • 13. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
    McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA.
    Cancer Prev Res (Phila); 2009 Jul 01; 2(7):673-82. PubMed ID: 19542190
    [Abstract] [Full Text] [Related]

  • 14. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
    deVere White RW, Hackman RM, Soares SE, Beckett LA, Li Y, Sun B.
    Urology; 2004 Feb 01; 63(2):259-63. PubMed ID: 14972467
    [Abstract] [Full Text] [Related]

  • 15. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
    Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, Husband AJ, Pedersen JS, Frydenberg M, Risbridger GP.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 01; 11(12):1689-96. PubMed ID: 12496063
    [Abstract] [Full Text] [Related]

  • 16. Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.
    Henning SM, Wang P, Lee RP, Trang A, Husari G, Yang J, Grojean EM, Ly A, Hsu M, Heber D, Grogan T, Li Z, Aronson WJ.
    Food Funct; 2020 May 01; 11(5):4114-4122. PubMed ID: 32347270
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomy.
    Marschner N, Rüttinger D, Zugmaier G, Nemere G, Lehmann J, Obrist P, Baeuerle PA, Wolf A, Schmidt M, Abrahamsson PA, Reinhardt C, Heidenreich A.
    Urol Int; 2010 May 01; 85(4):386-95. PubMed ID: 20606402
    [Abstract] [Full Text] [Related]

  • 18. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S, Zhu X, Schroder FH, Roobol MJ.
    BJU Int; 2012 Dec 01; 110(11):1678-83. PubMed ID: 22998182
    [Abstract] [Full Text] [Related]

  • 19. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC.
    Nutr Cancer; 2008 Dec 01; 60(4):483-91. PubMed ID: 18584482
    [Abstract] [Full Text] [Related]

  • 20. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
    Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G.
    Prostate; 2013 Jun 01; 73(9):970-8. PubMed ID: 23335089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.